- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00629161
Clinical Trial on the Effectiveness of Traditional Chinese Medicinal Mixture in Parkinson Disease
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The design of the study was a prospective, randomized, multicenter, double-blind placebo-controlled protocol. The intervention includes Traditional Chinese Medicinal Mixture tid or matched placebo.
Participating study centers include Neurological University Outpatient Clinics and Neurological Departments of Community-based Hospitals experienced with PD patients.
The primary outcome measure was the combined Unified Parkinson's Disease Rating Scale (UPDRS).
The hypothesis of this study was that Traditional Chinese Medicinal Mixture improves the overall wellbeing of PD patients and thus may leads to an improvement of parkinsonian symptoms in PD patients.
Study Type
Enrollment (Anticipated)
Phase
- Phase 2
- Phase 3
Contacts and Locations
Study Contact
- Name: Dingfang Cai, MD
- Email: doctorcn@hotmail.com
Study Locations
-
-
Beijing
-
Beijing, Beijing, China, 100053
- Recruiting
- Department of Neurology, Xuanwu hospital, Capital University of Medical Sciences
-
Contact:
- Li Gao, MD
-
-
Shanghai
-
Shanghai, Shanghai, China, 200032
- Recruiting
- Zhongshan Hospital, Fudan University
-
Contact:
- Dingfang Cai, MD
- Email: doctorcn@hotmail.com
-
Shanghai, Shanghai, China, 200065
- Recruiting
- Tongji Hospital of Tongji University
-
Contact:
- Qing Zhan, MD
-
Shanghai, Shanghai, China, 200025
- Recruiting
- Department of neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
-
Contact:
- Qin Xiao, MD
-
Shanghai, Shanghai, China, 200032
- Recruiting
- Department of Nuerology, Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
-
Contact:
- Canxing Yuan, MD
-
Shanghai, Shanghai, China, 200071
- Recruiting
- Shanghai Chinese Medical Hospital
-
Contact:
- Yi Liu, MD
-
Shanghai, Shanghai, China, 200127
- Recruiting
- Department of Nuerology, Xinhua Hospital, Affiliated to Shanghai Jiaotong University School of Medicine
-
Contact:
- Zhenguo Liu
-
Shanghai, Shanghai, China, 200233
- Recruiting
- The Sixth People's Hospital, Shanghai Jiaotong University
-
Contact:
- Xiaojiang Sun, MD
-
Shanghai, Shanghai, China, 200437
- Recruiting
- Department of Neurology, Yueyang Hospital of Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine
-
Contact:
- Hong Zhao, MD
-
-
Zhejiang
-
Wenzhou, Zhejiang, China, 325000
- Recruiting
- Department of Neurology, The second people's hospital of Wenzhou
-
Contact:
- Liya Han
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Parkinson's disease according to the UK Brain Bank criteria
- Hoehn & Yahr stadium Ⅰ~Ⅲ
- Age over 50 years
- Taking only levodopa and/or dopamine agonists when recruiting
- Consistent with the liver kidney deficiency type by Traditional Chinese Medicine (TCM) standard
- Patients voluntarily take part in this study and signed the informed consent
Exclusion Criteria:
- Modified Hoehn-Yahr scale are higher than 4
- Had other serious illness such as liver/kidney failure, serious infection etc
- Allergic to the study drug
- Had been participated in other clinical trials during the last 3 months prior to study inclusion.
- Taking Coenzyme Q10, MAO-B inhibitors, or vitamin E, all of which might improve the symptom or slowdown the progression of PD.
- Taking herbal medicine that can nourish the liver and kidney by TCM standard.
- Had serious mental disorder and could not describe his/her symptom.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: A
|
12 months period of Traditional Chinese Medicinal Mixture per day plus 1 month wash-out period without herbal medicine
|
Placebo Comparator: B
|
12 months period of placebo plus 1 month period without placebo
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Unified Parkinson's Disease Rating Scale (UPDRS)
Time Frame: 13 months
|
13 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Hoehn & Yahr scale
Time Frame: 13 months
|
13 months
|
Schwab & England score
Time Frame: 13 months
|
13 months
|
The liver kidney deficiency scale score by Traditional Chinese Medicine standard
Time Frame: 13 months
|
13 months
|
Dose of levodopa per day
Time Frame: 13 months
|
13 months
|
Dose of dopamine Agonists per day
Time Frame: 13 months
|
13 months
|
Parkinson disease sleep scale (PDSS)
Time Frame: 13 months
|
13 months
|
Assessment of autonomic dysfunction in Parkinson disease (SCOPA-AUT)
Time Frame: 13 months
|
13 months
|
Changes in laboratory indexes as safety assessment, including red blood cell(RBC), white blood cell(WBC), platelet(PLT), alanine transaminase(ALT), aspartate transaminase (AST), blood urea nitrogen (BUN), creatinine(Cr) in blood samples, ect.
Time Frame: 12 months
|
12 months
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2006BAI04A11-3
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Parkinson Disease
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedParkinson Disease 6, Early-Onset | Parkinson Disease (Autosomal Recessive, Early Onset) 7, Human | Parkinson Disease Autosomal Recessive, Early Onset | Parkinson Disease, Autosomal Recessive Early-Onset, Digenic, Pink1/Dj1United States
-
ProgenaBiomeRecruitingParkinson Disease | Parkinsons Disease With Dementia | Parkinson-Dementia Syndrome | Parkinson Disease 2 | Parkinson Disease 3 | Parkinson Disease 4United States
-
King's College LondonGlaxoSmithKlineCompletedParkinson Disease | Idiopathic Parkinson Disease | Parkinson Disease, PARK8United Kingdom
-
Ohio State UniversityCompletedParkinson's Disease | Parkinson Disease | Idiopathic Parkinson Disease | Idiopathic Parkinson's Disease | Parkinson Disease, Idiopathic | Parkinson's Disease, IdiopathicUnited States
-
National Yang Ming UniversityUnknownEarly Onset Parkinson Disease | Early Stage Parkinson Disease
-
Michele Tagliati, MDRecruitingREM Sleep Behavior Disorder | Symptomatic Parkinson Disease | Pre-motor Parkinson DiseaseUnited States
-
Cedars-Sinai Medical CenterEnrolling by invitationREM Sleep Behavior Disorder | Symptomatic Parkinson Disease | Pre-motor Parkinson DiseaseUnited States
-
Mahatma Gandhi Institute of Medical SciencesCompletedStroke, Parkinson' s Disease, Neurological Impairments, Tele-rehabilitationIndia
-
Merck Sharp & Dohme LLCCompletedParkinson Disease | Idiopathic Parkinson Disease | Idiopathic Parkinson's Disease
-
University of DeustoCompletedPARKINSON DISEASE (Disorder)Spain
Clinical Trials on Traditional Chinese Medicinal Mixture (composed of Roucongrong and adjuvant)
-
Fudan UniversitySizuoUnknown
-
Capital Medical UniversityCompleted
-
Lo-Sheng SanatoriumCompletedPlaque | Xerostomia | Leprosy | Hansen's DiseaseTaiwan
-
Medical University of GrazUnknownQuality of Life | Breast Cancer | Lung Cancer | Cholangiocarcinoma | Advanced Cancer | Pancreas Cancer | Colo-rectal Cancer | Symptoms and SignsAustria
-
Beijing University of Chinese MedicineRecruitingDegenerative Lumbar Spinal StenosisChina
-
Capital Medical UniversityUnknown
-
University of AlbertaRecruitingInsulin Resistance | Obesity, ChildhoodCanada
-
Children's Hospital of Fudan UniversityCompleted
-
Taichung Veterans General HospitalCompleted
-
Hadassah Medical OrganizationUnknownCoronary Artery Disease,Israel